Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer
about
Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic TherapyInternalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugatesScavenger-receptor targeted photodynamic therapy.In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour.Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor ModalitiesEpidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cellsLabel-Free, Longitudinal Visualization of PDT Response In Vitro with Optical Coherence TomographyBiodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancerPegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy.Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: perspective and results.Strategies for enhanced photodynamic therapy effects.Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapyPhotonanomedicine: a convergence of photodynamic therapy and nanotechnology.Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.Photosensitiser-antibody conjugates for photodynamic therapy.Antibody-based imaging strategies for cancer.Antibodies armed with photosensitizers: from chemical synthesis to photobiological applications.Porphyrin modified trastuzumab improves efficacy of HER2 targeted photodynamic therapy of gastric cancer.The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy.Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates.Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo.Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
P2860
Q28079955-91E5B0DB-31ED-4C91-A296-3CFAA9F5152BQ28366253-735CD7EB-B92F-4D07-8614-4375CB295D12Q30949312-7C5332DA-7975-4876-99B2-C467938B30FCQ33178931-FFC711D2-B1A5-42FE-A32F-8D608B070109Q33664307-9669EA22-0A8F-4358-9D38-B4BF8D08F4C4Q35973340-22D4FE30-265E-42D7-A2EC-B0B3C2F0F16EQ36513863-7EA28946-47A4-4B06-9DAC-FA0A2A19AF04Q36621534-6AB39317-C07E-4F7A-AE2B-ED493C9CD806Q36671748-2E115F9A-37DE-4BC7-BB1D-6E533D381A12Q36790826-CFCB368E-958D-4F30-BF02-7FB28F21C105Q36945978-9E7EF56C-4458-44FD-9584-53505337C81CQ36982369-55BEC31B-896B-4D5A-967B-BB9167A86F71Q37115994-3DD9EB09-7487-4EED-93E4-DA66DDE4F9EDQ37676077-6D64DAEA-8F19-43F6-A81B-C5776B68DDEAQ37853421-454D7846-2BF4-44E7-8977-4367303CF7F3Q38218986-F01ACF70-0620-4DC8-B8C6-3116C5AE73ADQ38328583-086C30EF-BE7D-4038-B1EE-F6EF71C30801Q38699434-7FDC8390-3FB7-40CD-BCF1-C873636ECD56Q40438375-0FA419DF-380D-4FD3-B0DC-0567FE55776CQ41850842-126D194A-7AEE-4527-956F-69982A1C0B62Q42142824-895BAB4E-F151-45DF-9A39-C7FB329EEADFQ47599219-C7D1A92D-81B3-420D-811D-C3577FCB0B18
P2860
Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Biodistribution of charged F(a ...... ograft model of ovarian cancer
@ast
Biodistribution of charged F(a ...... ograft model of ovarian cancer
@en
type
label
Biodistribution of charged F(a ...... ograft model of ovarian cancer
@ast
Biodistribution of charged F(a ...... ograft model of ovarian cancer
@en
prefLabel
Biodistribution of charged F(a ...... ograft model of ovarian cancer
@ast
Biodistribution of charged F(a ...... ograft model of ovarian cancer
@en
P2093
P2860
P356
P1476
Biodistribution of charged F(a ...... ograft model of ovarian cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1997.149
P407
P577
1997-01-01T00:00:00Z